Company: NEOG
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0000950170-25-005818
Chunk: 14

Company: NEOGEN CORP
Filing Date: 2025-01-15
Form: 10-Q
Item: Item 1
Chunk 14
---
 comprehensive loss

        -

        264

        -

        840

        Balance at end of period
         
        $
        -

        $
        (87
        )
         
        $
        -

        $
        (87
        )

        Fair value of derivatives change

        Balance at beginning of period
         
        $
        (1,995
        )
         
        $
        917

        $
        1,864

        $
        (2,039
        )

        Other comprehensive gain (loss) before reclassifications

        1,644

        229

        (1,627
        )

        3,708

        Amounts reclassified from accumulated other comprehensive loss

        (392
        )

        (580
        )

        (980
        )

        (1,103
        )

        Balance at end of period
         
        $
        (743
        )
         
        $
        566

        $
        (743
        )
         
        $
        566

        Accumulated other comprehensive loss, ending balance
         
        $
        (44,745
        )
         
        $
        (25,128
        )
         
        $
        (44,745
        )
         
        $
        (25,128
        )

15

PART I – FINANCIAL INFORMATION 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 

The information in this Management’s Discussion and Analysis of Financial Condition and Results of Operations contains both historical financial information and forward-looking statements. Neogen does not provide forecasts of future financial performance. While management is optimistic about the Company’s long-term prospects, historical financial information may not be indicative of future financial results. 

Safe Harbor and Forward-Looking Statements 

Forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, are made throughout this Quarterly Report on Form 10-Q, including statements relating to management’s expectations regarding new product introductions; the adequacy of our sources for certain components, raw materials and finished products; and our ability to utilize certain inventory. For this purpose, any statements contained herein that are not statements of historical fact are deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “seeks,”